We are delighted to announce that the International Wound Journal (IWJ) has published our landmark multi-centre randomised self-controlled trial (RCT). The study compares standard of care (SoC) with and without the geko™ device in patients with hard-to-heal venous leg ulcers (VLUs) and reports an acceleration in...
The geko™ device has officially been assessed and certified with meeting the requirements of Part II of The Medical Devices Regulations 2002, Annex II (excluding section 4), for: Increased blood circulation, for the prevention of venous thrombosis Prevention of oedema Treatment of venous insufficiency and...
The Department for International Trade (DIT) has named Sky Medical Technology part of their international showcase of UK exporters of innovative MedTech making waves globally. Getting selected has allowed us to represent the UK at key overseas events, including being profiled in DIT campaigns in key...
Five MedTech trends to shape healthcare in 2023 Since the initial COVID-19 outbreaks sent the nation into lockdown three years ago, our healthcare system has been facing disruption while under resourced and tackling backlogs – the waiting list for elective surgery has now reached a record...
Hyponatremia and hypernatremia are medical conditions for imbalanced levels of sodium in the blood. These imbalances can increase the risk of life-threatening blood clots (venous thromboembolisms or ‘VTEs’) in hospital patients, especially the elderly and critically ill undergoing surgery. Hospital acquired VTE is one of the...
Technological advancements like the geko™ device have the potential to usher in a new era in the treatment of venous leg ulcers (VLUs) – a wound on the leg or ankle caused by abnormal or damaged veins. Wounds such as these are common and can...
A rising risk Venous thromboembolism (VTE) – more commonly known as a blood clot – is one of the leading causes of death globally, with one in four people dying every year. The risk of VTE increases by up to five times during pregnancy with 1-2...
Getting It Right First Time (GIRFT) is a national healthcare programme designed to regularly improve the delivery of patient care through comprehensive reviews of current services providing data-driven evidence that can implement change. Through GIRFT, senior clinicians across various care pathways can directly review current treatment...
We are seeking senior level tissue viability nurses (TVNs), willing to embrace and drive innovation advance, to join our Partner-With-Us program. The Partner-With-Us program precedes the imminent publication of a statistically significant randomised controlled study that compares the rate of wound healing in chronic venous leg...
We recently welcomed Fiona Young as the new director for wound care therapy at Sky Medical Technology! Fiona has joined the team to lead the market adoption of the geko™ device for the healing of leg ulcers – a condition that affects millions of people...